Compare Organon Pharma Indonesia Tbk. (SCPI) vs Sunter Lakeside Hotel Tbk. (SNLK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Organon Pharma Indonesia Tbk. vs Sunter Lakeside Hotel Tbk. — how do they compare? Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B), while Sunter Lakeside Hotel Tbk. trades at Rp234 (market cap 102.6B, 15.47M 24h volume). The key difference: Organon Pharma Indonesia Tbk. and Sunter Lakeside Hotel Tbk. are close in size by market cap. Which is the better fit depends on your goals.
| SCPI | SNLK | |
|---|---|---|
Market Cap | 104.4B | 102.6B |
Volume | — | 15.47M |
Lot | — | 154.71K |
Turnover | — | 3.55B |
Average Price | — | 229.28 |
Value | — | 3.55B |
Indicative Equilibrium Price | — | 234 |
Indicative Equilibrium Volume | — | 80 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →About Sunter Lakeside Hotel Tbk.
PT Sunter Lakeside Hotel Tbk (the Company) was established based on Notarial Deed No. 32 dated November 15, 1991, of Tjoek Ratriawan, S.H. Notary in Jakarta. The Company started its commercial operations on November 01, 1995.
Read more on SNLK →
